From new WHO guidance on TB & diabetes to innovations workshops, climate frameworks, and global commitments, 2025 is a pivotal year in the fight to #EndTB. Progress is happening, but action must continue. 🩺 #GlobalHealth

New meta-analysis finds no clear mortality benefit from intensified treatment regimens (ie. high-dose rifampicin, fluoroquinolones) for #tuberculous #meningitis in adults. More consistent, high-quality trials needed. 📚 pubmed.ncbi.nlm.nih.gov/41064692/

New study in PLOS ONE analyzes 255 messages between TB patients & treatment supporters using digital adherence tech (DATs). Beyond reminders, patients need empathy, support & better usability. 📖 pubmed.ncbi.nlm.nih.gov/40705794/ #TB #mHealth #DigitalHealth

🩺New study compares 4R10 vs 2R20 regimens for latent TB. No major cost difference, but meds + follow-ups are biggest drivers. Fewer visits could cut costs, depending on setting. 🔗 pubmed.ncbi.nlm.nih.gov/40980570/ #TB #TPT #GlobalHealth #PublicHealth

🧬 TB remains one of the world’s top infectious killers. Where, in your opinion, should innovation funding go next? 🟦 Diagnostics 🟦 Shorter treatments 🟦 Vaccines 🟦 Health systems 🌐 Read the WHO Global TB Report 2024: www.who.int/teams/global... #TB #GlobalHealth #InfectiousDiseases #WHO

🩺 WHO now recommends a 6-month all-oral regimen for drug-resistant TB: shorter, safer, and easier to complete. A major step forward in global TB care. 📄 Full update: www.who.int/news/item/15... #TB #GlobalHealth

🧠 UN: Children face a “new era of crisis.” For TB, this means more gaps in #care, fragile systems, and kids left behind. We can’t end #TB without reaching the most vulnerable. 🔗 news.un.org/en/story/202... #EndTB #ChildHealth #GlobalHealth

❤️ On #WorldHeartDay, a reminder: #TB can affect more than lungs, it can influence hearts. New research shows 1 in 5 patients with tuberculous pericarditis develop deadly heart failure post-surgery. Early care matters. 🔗 www.sciencedirect.com/science/arti... #EndTB #HeartHealth

🩺 New Lancet study: Men are ~1.7x more likely than women to be infected w/ #TB due to biology and gendered factors. Question for you: How can we design TB strategies that reflect real sex & gender differences without oversimplifying? 🔗 www.thelancet.com/journals/lan... #GlobalHealth #HealthEquity

New NEJM study shows 3 oral, 9-month regimens are noninferior for rifampin-resistant #TB. A win for patient-centered care + policy updates. 🔗 www.nejm.org/doi/full/10.... #TB #GlobalHealth #HealthPolicy #InfectiousDisease

🧠Rethinking TB care: Integration isn’t a burden; it’s a cost-effective, people-centred strategy. A new @thelancet.com article makes the case for linking #TB, lung health & shared risks. 🔗 www.thelancet.com/journals/lan... #Tuberculosis #LungHealth #GlobalHealth #PublicHealth #TheLancet

🧪 New stool #qPCR test improves pediatric #TB detection in high-burden settings! It's #non-invasive, has a high specificity, and improves pediatric TB detection where sputum or gastric sample collection is challenging. 🔗 academic.oup.com/jpids/articl... #PediatricTB #GlobalHealth #Diagnostics

Good food is part of the fight against TB . Let’s make nutrition a priority for everyone on treatment! #EndTB youtu.be/VYQOKK7wIjI

🚨 Exciting global health opportunity! @isglobal.org is hiring a Medical Research Fellow (Tuberculosis) in Manhiça, Mozambique. Lead impactful TB research with a top team. 🩺 MD + 4yrs clinical exp 🗓️ 2-yr contract 🔗 Apply: jobs.isglobal.org/jobs/6376227 #GlobalHealth #TB #ResearchJobs #PublicHealth

🔍 New MTBI-led study shows gaps in #TB awareness in #Mozambique particularly among adults w/ #HIV and caregivers of children. 🛑 Low TB knowledge ⚠️ Stigma 🚫 Gender barriers Call for community-driven interventions. 📖 journals.plos.org/globalpublic... #GlobalHealth #PublicHealth #HealthEquity

🙌🏾Yesterday marked a truly memorable moment! The very first @mtbi.bsky.social Initiative Forum was a resounding success! 🤝It brought together passionate experts and researchers to exchange ideas on #TB prevention & explore exciting developments in vaccine research.

The day has arrived! Don’t miss our very first @mtbi.bsky.social Forum today alongside the 4th Manhiça Foundation Global Health Symposium. ➡️ Follow it online: lnkd.in/dbJT_KWG @isglobal.org @fundacionareces.bsky.social eces.bsky.social @acesurafrica.bsky.social africa.bsky.social @manhica_cism

💥We are delighted to announce that our initiative @mtbi.bsky.social will be hosting its first-ever Forum, taking place alongside the 4th Edition of the Manhiça Foundation Global Health Symposium, on July 22! 📝Register to attend virtually or in person: www.cismmanhica.org/simposio25

We just published a piece about the participation of people deprived of liberty in #tuberculosis vaccine trials. Should they be protected from research, or through research? www.thelancet.com/journals/lan... @thelancetinfdis.bsky.social @isglobal.org @mtbi.bsky.social

💥Today we share great news! @agbasteiro.bsky.social has been honored with the XX Banc Sabadell Foundation Award for Biomedical Research! 👏🏾 🔗 fundacionbancosabadell.com/la-fundacion... #PremiosBiomédicaCiencias #LaCulturadelTalento #Investigación

We participated in the European Advanced Course in Clinical Tuberculosis #EACCTB 2025, organized by TBnet. Our PI @agbasteiro.bsky.social was an invited speaker on the clinical spectrum of TB, contributing to the scientific exchange with his expertise. #endTB #GlobalHealth #MTBI

🚨Our paper published in @thelancet.com calls for the ethical inclusion of people in prison in TB vaccine trials. Despite facing a disproportionately high burden of #TB & other infectious diseases, incarcerated populations are routinely excluded from research. www.isglobal.org/en/-/ensayos...

#MTBI was proud to join the 12th #EDCTP Forum last week in Kigali, Rwanda. The event brought together global leaders to advance clinical research and partnerships in sub-Saharan Africa. A great opportunity to connect, share insights, and support better health through global collaboration.

The #Stool4TB Consortium Annual Meeting in Eswatini kicked off with opening remarks from Dr. @agbasteiro.bsky.social, PI of the #MTBI initiative, and Ms. Rejoice Nkambule, Deputy Director of Public Health at Eswatini’s Ministry of Health.

✨The final annual meeting of the #Stool4TB Consortium in Mbabane, Eswatini, was a great success — marking the conclusion of five years of collaborative research to improve tuberculosis diagnosis. Partners from across Eswatini, Uganda, and Mozambique came together to celebrate a major milestone!

Today we had the pleasure of welcoming Professor Rafael Prados-Rosales from the Department of Preventive Medicine, Public Health and Microbiology at the Universidad Autónoma de Madrid (UAM). During his visit to #CISM in Manhiça, he presented a highly relevant and insightful article. Thank you!

👏🏾Thank you, TBnet Academy, for having us! It has been a pleasure to be part of this forum — sharing knowledge, exchanging ideas, and contributing expert mentorship in the field of tuberculosis. We truly value these spaces for scientific exchange and collaboration. #TBnetAcademy #endTB #MTBI

🟡 We're pleased to be participating in the TBnet Academy in Tirana this week! 📸 Today, Dr. @agbasteiro.bsky.social delivered a talk on Asymptomatic Tuberculosis, sharing insights on one of the most challenging aspects of TB control. #TBnetAcademy #endTB #MTBI

💥The PI and coordinator of our initiative #MTBI, @agbasteiro.bsky.social has been awarded the distinction of Fellow of ERS (FERS), by the European Respiratory Society (ERS), which is one of the most prestigious honors in the field of respiratory medicine. 🙌👏 www.isglobal.org/en/-/alberto...

El periódico @eldia.es ha publicado nuestra investigación, sobre el análisis molecular de muestras de heces como herramienta eficaz para el diagnóstico de TB, especialmente en personas con VIH, donde las muestras de esputo son difíciles de obtener. 👏📰 www.eldia.es/sociedad/202...

Hoy, #DíaMundialDeLaInmunización, subrayamos la importancia de las #vacunas para la #SaludGlobal y nos fijamos en la vacuna contra el Virus del Papiloma Humano (#VPH). ¿Sabías que reduce el riesgo de desarrollar algunos tipos de cáncer? 🟠https://f.mtr.cool/mmyomqnfpo #VaccinesWork

➡️John Green’s latest book, Everything is Tuberculosis, explores the paradox of TB being a curable disease that still claims over a million lives every year. This Atmos article draws parallels between TB and climate change: a systemic injustice and hits the most vulnerable hardest. goo.su/IUnP

💡 Our Journal Club, is an excellent opportunity to stay up to date with #TB developments & engage in insightful discussions about selected articles. This week Amélia Honwana, Medical Doctor at #CISM, presented an article on the immunogenicity of the vaccine H56:IC31 in reducing TB. #MTBI

👏📰El diario @larazonlr.bsky.social ha publicado nuestra investigación, que demuestra que el análisis molecular de muestras de heces puede ser una herramienta eficaz para el diagnóstico de TB, especialmente en personas con VIH, donde las muestras de esputo son difíciles de obtener. goo.su/5izrHS

Uno de nuestros estudios ​reciente publicado en @thelancet.bsky.social revela que el uso de la prueba molecular Xpert MTB/Ultra en muestras de heces podría mejorar significativamente la detección de tuberculosis en personas adultas con VIH. ➡️Lee más: www.clinicbarcelona.org/noticias/el-...

❕ Today, we recognize #WorldHealthDay, a moment to reflect on the progress we’ve made in global health and the challenges that still lie ahead. Health is a fundamental human right, yet millions around the world still lack access to basic care, safe environments, and essential support.

Sabies que la salut del planeta i la nostra estan connectades? Si volem tenir cura d'una, hem de tenir-ne de l'altra. Avui, #DiaMundialDeLaSalut, et parlem d'aquest concepte #EnMenysDUnMinut. Trobaràs més vídeos d'aquesta sèrie al nostre #TikTok: 🟠https://bit.ly/ISGlobal_TikTok

💥Great news! Today, we published a new article in @thelancet.bsky.social on the efficacy of the stool Xpert MTB/RIF Ultra test for detecting tuberculosis in HIV-positive adults, particularly in resource-limited settings. Full article: www.thelancet.com/journals/lan...

A few days ago, we shared our publication in @thelancet.bsky.social, challenging traditional TB detection methods. Check out this insightful blog from @joannaehrlich.bsky.social on how half of the world’s TB cases fly under the radar, emphasizing the need for better screening. acortar.link/r310Lw

❕Necesaria cápsula de conocimiento sobre la #tuberculosis. 👏Gracias @isglobal.org www.tiktok.com/@isglobalorg...

💡 An interesting activity we organize is the Journal Club, an excellent opportunity to stay up to date with #TB developments & engage in insightful discussions about selected articles. This week, Caterina Velasco, Superior Lab Technician at #CISM, presented a study on TB diagnosis in children. #MTBI

👏🏾 El debate de ayer de #CaixaResearch sobre #Tuberculosis fue imprescindible. La enfermedad infecciosa más mortal del mundo fue analizada en profundidad por @agbasteiro.bsky.social, @pjcardona14.bsky.social e Iñaki Comas. ➡️ Si te lo perdiste, aún puedes verlo: www.youtube.com/watch?v=USQv...

❗Hoy participamos en un debate de Caixa Research sobre #TB. Estará uno de nuestros PI @agbasteiro.bsky.social, junto con @pjcardona14.bsky.social e Iñaki Comas, con la moderadora Jessica Mouzo. ¡No os lo perdáis! Apúntate: caixaresearch.org/es/debates-c... #endTB #MTBI #CaixaResearch

🫁 #Tuberculosis has once again become the deadliest infectious disease worldwide. Up to 68% of transmission can come from asymptomatic people. On #WorldTBDay, we shine a light on these silent infections: 🟠 www.isglobal.org/en/healthisg... @agbasteiro.bsky.social @joannaehrlich.bsky.social

🙌We are happy to share our publication released today in @thelancet.bsky.social, which challenges traditional TB detection methods and highlights the need for improved screening and research. 📰 Full text: www.thelancet.com/journals/lan...

Sim! Podemos Acabar com a Tuberculose: Compromisso, Investimento, Resultados. Hoje, Dia Mundial da #Tuberculose, reforçamos a urgência de agir contra esta doença. O CISM e seus parceiros têm se dedicado intensamente à pesquisa e ao desenvolvimento de novas ferramentas para prevenção e combate à TB

💥 Today we are reminded that TB is one of the deadliest infectious diseases worldwide. Despite being preventable and curable, millions of people still suffer from its effects. MTBI is committed to improving TB diagnosis, treatment, and prevention to move closer to its eradication. #endTB #WorldTBDay

🗞️News 📰Historic #TB outbreak a wake-up call for US policy makers Written by @bryantfurlow.bsky.social tinyurl.com/8u6nmf4a #EndTB #TBsky #tuberculosis @theunion-tblh.bsky.social

📰A recent @nytimes.com article discusses the consequences of recent U.S. cuts to #TB funding in Kenya. The U.S. has been a major supporter in TB research and treatment, and its reduced commitment raises concerns for public health initiatives & the future of TB elimination efforts. 👁️‍🗨️ lc.cx/QdElwO

🔬 #MTBI never stop learning to improve and continue growing as a team. Yesterday, some of our members participated in the Electrocardiography Update and Improvement Course, led by Dr. Neusa Jessen, which provided comprehensive insights into conducting and interpreting ECGs 👏